Evaluation status available after sign-in
About the journal
EJC Paediatric Oncology is an open-access journal published by Elsevier in United Kingdom, publishing in english. It is listed in DOAJ according to the sources read. Declared publication charge: 2,390 USD. Declared review time at DOAJ: 18 weeks. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.
Basic facts
- Publisher
- Elsevier
- ISSN
- 2772-610X
- Country
- United Kingdom
- Languages
- english
- Access
- Open access
- Declared publication charge
- 2,390 USD
- Articles in DOAJ
- 433
- Declared review time
- 18 weeks
- Declared peer-review model
- other
- Official website
- https://www.sciencedirect.com/journal/ejc-paediatric-oncology
Index listings
- DOAJ · 2023-08-30
- Indexing
- DOAJ
- APC
- 2,390 USD
- Declared review time (DOAJ)
- 18 weeks — journal-declared only (not measured)
- Activity (OpenAlex)
- Active — latest works 2026
- PublishLens list status
- Shown after sign-in
- Counts for promotion at your university?
- Choose your university and rank below ↓
Methodology signals (dated facts from their sources)
Details of the evaluation under the published methodology are shown to signed-in users (free).
Create a free account to view the evaluationJournal profile
Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.
Articles in DOAJ
433
Most recent article
2 months ago
Average review time (journal-declared via DOAJ)
18weeks
Works in OpenAlex
520
Last recorded publication year
2026
Reported by OpenAlex in 2 of 3 sources (CC0 flags, not verified indexing)DOAJSciELOOpenAlex Core
h-index
11
i10-index
11
From OpenAlex open data (CC0).
Editorial & policy12
- Last DOAJ review date
- 2026-04-27
- Added to DOAJ
- 2023-08-30
- Declared plagiarism screening
- Declared
- Other fees beyond APC
- No
- Declared digital preservation
- CLOCKSSPortico
- Observed digital preservation (Keepers registry)— snapshot 2026-10-05
- CLOCKSSPortico
- Editorial board
- Official page ↗
- Norwegian register (HK-dir)— 2026
- Level 1 — approved scholarly channel
- Open references deposited at Crossref
- 47%
- ORCID iDs in current deposits
- 31%
- Deposits licence metadata at Crossref
- ✓
- APC waiver policy
- View policy
- Peer-review policy
- View policy
Identity & continuity2
- Source type
- journal
- NLM unique ID (PubMed)
- 9918681488306676
Classification2
Subjects (DOAJ)
Medicine: Internal medicine: Neoplasms. Tumors. Oncology. Including cancer and carcinogens
LCC codes
RC254-282
Subject areas
- Acute Lymphoblastic Leukemia research
- Childhood Cancer Survivors' Quality of Life
- Childhood Cancer Survivors' Quality of Life
- Acute Myeloid Leukemia Research
- Neuroblastoma Research and Treatments
- Neuroblastoma Research and Treatments
- Blood disorders and treatments
- Neuroblastoma Research and Treatments
Show all subjects (75)
- Acute Lymphoblastic Leukemia research
- Acute Lymphoblastic Leukemia research
- Immunodeficiency and Autoimmune Disorders
- Hematopoietic Stem Cell Transplantation
- Childhood Cancer Survivors' Quality of Life
- Glioma Diagnosis and Treatment
- Sarcoma Diagnosis and Treatment
- Acute Myeloid Leukemia Research
- Acute Myeloid Leukemia Research
- Neutropenia and Cancer Infections
- Neurofibromatosis and Schwannoma Cases
- Glioma Diagnosis and Treatment
- Glioma Diagnosis and Treatment
- Cancer survivorship and care
- Protein Tyrosine Phosphatases
- Chronic Myeloid Leukemia Treatments
- Chronic Myeloid Leukemia Treatments
- Sarcoma Diagnosis and Treatment
- Sarcoma Diagnosis and Treatment
- Neutropenia and Cancer Infections
- Neutropenia and Cancer Infections
- Family Support in Illness
- Chronic Lymphocytic Leukemia Research
- CAR-T cell therapy research
- Chronic Lymphocytic Leukemia Research
- Family Support in Illness
- Retinoids in leukemia and cellular processes
- CAR-T cell therapy research
- Lymphoma Diagnosis and Treatment
- Genomics and Rare Diseases
- Hematological disorders and diagnostics
- Blood disorders and treatments
- Blood disorders and treatments
- Hematopoietic Stem Cell Transplantation
- Hematological disorders and diagnostics
- Hematological disorders and diagnostics
- Hematopoietic Stem Cell Transplantation
- Hemoglobinopathies and Related Disorders
- Hemoglobinopathies and Related Disorders
- Advances in Oncology and Radiotherapy
- CAR-T cell therapy research
- Lymphoma Diagnosis and Treatment
- Lymphoma Diagnosis and Treatment
- Lung Cancer Research Studies
- Autoimmune and Inflammatory Disorders Research
- Cancer, Hypoxia, and Metabolism
- Lung Cancer Research Studies
- Sepsis Diagnosis and Treatment
- Cancer, Hypoxia, and Metabolism
- Palliative Care and End-of-Life Issues
- Palliative Care and End-of-Life Issues
- Advanced Radiotherapy Techniques
- Chronic Myeloid Leukemia Treatments
- Congenital Diaphragmatic Hernia Studies
- Virus-based gene therapy research
- Congenital Diaphragmatic Hernia Studies
- Virus-based gene therapy research
- Cancer Immunotherapy and Biomarkers
- Global Cancer Incidence and Screening
- Adolescent and Pediatric Healthcare
- Adolescent and Pediatric Healthcare
- Immunodeficiency and Autoimmune Disorders
- Immunodeficiency and Autoimmune Disorders
- Pharmaceutical studies and practices
- Connective tissue disorders research
- Tumors and Oncological Cases
- Connective tissue disorders research
Keywords (DOAJ)
- paediatric ncology
- cchildhood cancer
- haemato-oncology
- solid tumours
- neuro-oncology
- cancer therapy
Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.
Loading community confirmations…
The journal's record in other sources:Web of Science MJLDOAJ